vs

Side-by-side financial comparison of Enpro Inc. (NPO) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $197.9M, roughly 1.5× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -10.8%, a 17.5% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs 13.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 7.1%).

Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

NPO vs RGEN — Head-to-Head

Bigger by revenue
NPO
NPO
1.5× larger
NPO
$295.4M
$197.9M
RGEN
Growing faster (revenue YoY)
NPO
NPO
+0.7% gap
NPO
14.3%
13.6%
RGEN
Higher net margin
RGEN
RGEN
17.5% more per $
RGEN
6.7%
-10.8%
NPO
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
7.1%
NPO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPO
NPO
RGEN
RGEN
Revenue
$295.4M
$197.9M
Net Profit
$-32.0M
$13.3M
Gross Margin
42.1%
52.5%
Operating Margin
11.2%
9.0%
Net Margin
-10.8%
6.7%
Revenue YoY
14.3%
13.6%
Net Profit YoY
-330.2%
143.9%
EPS (diluted)
$-1.50
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPO
NPO
RGEN
RGEN
Q4 25
$295.4M
$197.9M
Q3 25
$286.6M
$188.8M
Q2 25
$288.1M
$182.4M
Q1 25
$273.2M
$169.2M
Q4 24
$258.4M
$174.1M
Q3 24
$260.9M
$154.9M
Q2 24
$271.9M
$154.1M
Q1 24
$257.5M
$151.3M
Net Profit
NPO
NPO
RGEN
RGEN
Q4 25
$-32.0M
$13.3M
Q3 25
$21.6M
$14.9M
Q2 25
$26.4M
$14.9M
Q1 25
$24.5M
$5.8M
Q4 24
$13.9M
$-30.3M
Q3 24
$19.8M
$-654.0K
Q2 24
$26.7M
$3.3M
Q1 24
$12.5M
$2.1M
Gross Margin
NPO
NPO
RGEN
RGEN
Q4 25
42.1%
52.5%
Q3 25
41.9%
53.2%
Q2 25
43.3%
50.0%
Q1 25
43.3%
53.6%
Q4 24
42.3%
26.1%
Q3 24
42.3%
50.0%
Q2 24
43.8%
49.8%
Q1 24
41.2%
49.5%
Operating Margin
NPO
NPO
RGEN
RGEN
Q4 25
11.2%
9.0%
Q3 25
14.3%
8.9%
Q2 25
15.9%
7.6%
Q1 25
15.3%
3.9%
Q4 24
12.5%
-17.7%
Q3 24
13.1%
-5.1%
Q2 24
17.7%
1.0%
Q1 24
10.9%
1.3%
Net Margin
NPO
NPO
RGEN
RGEN
Q4 25
-10.8%
6.7%
Q3 25
7.5%
7.9%
Q2 25
9.2%
8.2%
Q1 25
9.0%
3.4%
Q4 24
5.4%
-17.4%
Q3 24
7.6%
-0.4%
Q2 24
9.8%
2.2%
Q1 24
4.9%
1.4%
EPS (diluted)
NPO
NPO
RGEN
RGEN
Q4 25
$-1.50
$0.24
Q3 25
$1.01
$0.26
Q2 25
$1.25
$0.26
Q1 25
$1.15
$0.10
Q4 24
$0.65
$-0.55
Q3 24
$0.94
$-0.01
Q2 24
$1.27
$0.06
Q1 24
$0.59
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPO
NPO
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$114.7M
$767.6M
Total DebtLower is stronger
$655.3M
$542.2M
Stockholders' EquityBook value
$1.5B
$2.1B
Total Assets
$2.7B
$2.9B
Debt / EquityLower = less leverage
0.42×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPO
NPO
RGEN
RGEN
Q4 25
$114.7M
$767.6M
Q3 25
$132.9M
$748.7M
Q2 25
$107.1M
$708.9M
Q1 25
$240.3M
$697.2M
Q4 24
$236.3M
$757.4M
Q3 24
$206.9M
$784.0M
Q2 24
$175.9M
$809.1M
Q1 24
$163.9M
$780.6M
Total Debt
NPO
NPO
RGEN
RGEN
Q4 25
$655.3M
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$640.1M
$525.6M
Q3 24
Q2 24
Q1 24
$644.9M
Stockholders' Equity
NPO
NPO
RGEN
RGEN
Q4 25
$1.5B
$2.1B
Q3 25
$1.5B
$2.1B
Q2 25
$1.5B
$2.1B
Q1 25
$1.5B
$2.0B
Q4 24
$1.4B
$2.0B
Q3 24
$1.5B
$2.0B
Q2 24
$1.4B
$2.0B
Q1 24
$1.4B
$2.0B
Total Assets
NPO
NPO
RGEN
RGEN
Q4 25
$2.7B
$2.9B
Q3 25
$2.4B
$2.9B
Q2 25
$2.4B
$2.9B
Q1 25
$2.5B
$2.9B
Q4 24
$2.5B
$2.8B
Q3 24
$2.5B
$2.8B
Q2 24
$2.5B
$2.9B
Q1 24
$2.5B
$2.8B
Debt / Equity
NPO
NPO
RGEN
RGEN
Q4 25
0.42×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.45×
0.27×
Q3 24
Q2 24
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPO
NPO
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPO
NPO
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$65.3M
$48.1M
Q2 25
$52.2M
$28.6M
Q1 25
$21.0M
$15.0M
Q4 24
$59.4M
$39.2M
Q3 24
$54.0M
$49.3M
Q2 24
$43.2M
$42.2M
Q1 24
$6.3M
$44.7M
Free Cash Flow
NPO
NPO
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$53.4M
$43.4M
Q2 25
$42.3M
$21.5M
Q1 25
$13.0M
$11.4M
Q4 24
$49.1M
$33.6M
Q3 24
$48.3M
$42.3M
Q2 24
$38.3M
$37.4M
Q1 24
$-1.9M
$36.4M
FCF Margin
NPO
NPO
RGEN
RGEN
Q4 25
8.9%
Q3 25
18.6%
23.0%
Q2 25
14.7%
11.8%
Q1 25
4.8%
6.8%
Q4 24
19.0%
19.3%
Q3 24
18.5%
27.3%
Q2 24
14.1%
24.3%
Q1 24
-0.7%
24.0%
Capex Intensity
NPO
NPO
RGEN
RGEN
Q4 25
4.1%
4.1%
Q3 25
4.2%
2.5%
Q2 25
3.4%
3.9%
Q1 25
2.9%
2.1%
Q4 24
4.0%
3.2%
Q3 24
2.2%
4.5%
Q2 24
1.8%
3.1%
Q1 24
3.2%
5.5%
Cash Conversion
NPO
NPO
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.02×
3.23×
Q2 25
1.98×
1.92×
Q1 25
0.86×
2.57×
Q4 24
4.27×
Q3 24
2.73×
Q2 24
1.62×
12.70×
Q1 24
0.50×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPO
NPO

Sealing Technologies Segment$187.0M63%
General Industrial$71.3M24%
Power Generation$19.9M7%
Oiland Gas Market$15.0M5%
Semiconductors$2.2M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons